Pneumocystis jiroveci Pneumonia in an Atypical Host

Clin Breast Cancer. 2012 Apr;12(2):138-41. doi: 10.1016/j.clbc.2011.10.003. Epub 2011 Dec 1.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Anti-Infective Agents / therapeutic use
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bendamustine Hydrochloride
  • Bevacizumab
  • Breast Neoplasms / complications*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / pathology
  • CD4 Lymphocyte Count
  • Clinical Trials, Phase I as Topic
  • Dexamethasone / therapeutic use
  • Erlotinib Hydrochloride
  • Female
  • Humans
  • Lung Neoplasms / complications*
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / secondary
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy
  • Nitrogen Mustard Compounds / administration & dosage
  • Paclitaxel / administration & dosage
  • Pneumocystis carinii
  • Pneumonia, Pneumocystis / complications*
  • Pneumonia, Pneumocystis / drug therapy
  • Pneumonia, Pneumocystis / physiopathology
  • Quinazolines / administration & dosage
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

  • Adrenal Cortex Hormones
  • Anti-Infective Agents
  • Antibodies, Monoclonal, Humanized
  • Nitrogen Mustard Compounds
  • Quinazolines
  • Bevacizumab
  • Dexamethasone
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Bendamustine Hydrochloride
  • Erlotinib Hydrochloride
  • Paclitaxel